Mackay Shields LLC Reata Pharmaceuticals Inc Transaction History

Mackay Shields LLC

  • $581 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 31, 2020
SELL
$126.3 - $176.56 $1.04 Million - $1.45 Million
-8,200 Closed
0 $0
Q1 2020

May 08, 2020
SELL
$124.16 - $247.74 $49,664 - $99,096
-400 Reduced 4.65%
8,200 $1.18 Million
Q4 2019

Feb 11, 2020
BUY
$74.57 - $217.92 $641,301 - $1.87 Million
8,600 New
8,600 $1.76 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Mackay Shields LLC Portfolio

Follow Mackay Shields LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email